Strategic positioning On Target specializes in intraoperative molecular imaging to illuminate cancer during surgery, presenting a compelling value proposition for hospitals and surgical centers aiming to improve oncologic outcomes and margin clearance. Sales conversations can target surgical oncology programs and cancer centers seeking advanced visualization tools.

Growth and visibility Recognition as a World’s Most Innovative Company in 2026 enhances credibility with potential customers and investors. Leverage this accolade in outreach to risk-averse procurement teams and academic medical centers evaluating innovative surgical imaging solutions.

Funding and leadership Strong funding history (Series C and beyond) and executive leadership changes signal a growth phase with potential for rapid adoption and partnerships. Engage corporate development and strategic alliance teams at academic hospitals and biopharma collaborators seeking co-development or companion diagnostics opportunities.

Market fit opportunities The company’s technology targets intraoperative cancer visualization across oncologic surgeries, aligning with hospital initiatives to reduce positive margin rates and reoperations. Focus BD efforts on surgical departments, pathology, and OR committees prioritizing advanced imaging modalities.

Technology and integrations Existing tech stack and digital presence suggest readiness for enterprise partnerships and clinical trial collaborations. Position opportunities around data integration with imaging workflows, EHR/clinical data capture, and potential use in multi-center trials.